Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ningling Sun

Showing results (41-50 of 95) with videos related to

Pageof 10
Sort By:
Clinical Cardiology|October 29, 2015
Effects of Anxiety and Depression on Arterial Elasticity of Subjects With Suboptimal Physical HealthNingling Sun, Yang Xi, Zhiming Zhu, et al.
Pharmacogenomics and Personalized Medicine|December 25, 2024
Associations Between the Polymorphisms in the Coding Sequence of SLCO1B1 and Blood Lipid Levels Before and After Treatment by Atorvastatin in the Chinese Han Adults with DyslipidemiaChao Chen, Yan Tian, Fengshun Jia, et al.
Blood Pressure|June 2, 2025
Impact of amlodipine-based therapy on blood pressure time in target range in Chinese adults with primary hypertension: a retrospective studyHongyi Wang, Yuqing Zhang, Jinxiu Lin, et al.
Advances in Therapy|February 10, 2025
Real-World Multicenter Registry to Determine Management and Quality of Care of Patients with Type 2 Diabetes, Hypertension, Heart Failure and/or Chronic Kidney Diseases in China (iCaReMe China)Xiaoling Cai, Wenjia Yang, Bo Feng, et al.
American Journal of Hypertension|January 25, 2021
A Method for Estimating 24-Hour Urinary Sodium Excretion by Casual Urine Specimen in Chinese Hypertensive PatientsYan Sun, Hongyi Wang, Hao Liang, et al.
International Journal of Cancer|January 23, 2013
Folic acid supplementation and cancer risk: a meta-analysis of randomized controlled trialsXianhui Qin, Yimin Cui, Lin Shen, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|July 16, 2024
The prevalence of monotherapy and combination therapy in hypertension in China from 2019 to 2021: A nationwide population-based cross-sectional studyXiaoyang Luo, Wei Liu, Ningling Sun, et al.
Experimental and Therapeutic Medicine|April 29, 2017
Efficacy and tolerability of once-daily 160 mg valsartan in Chinese patients with mild to moderate hypertensionNingling Sun, Yingqing Feng, Pingjin Gao, et al.
Pharmacogenetics and Genomics|June 7, 2024
Exploring CYP2D6 polymorphisms and angiotensin receptor blocker response in the Bai hypertensive populationCanbiao Yang, Guoqiang Zhang, Chang Shu, et al.
Hypertension (Dallas, Tex. : 1979)|January 22, 2014
Efficacy and safety of LCZ696, a first-in-class angiotensin receptor neprilysin inhibitor, in Asian patients with hypertension: a randomized, double-blind, placebo-controlled studyKazuomi Kario, Ningling Sun, Fu-Tien Chiang, et al.
Pageof 10

Showing results (41-50 of 95) with videos related to

Sort By:
Pageof 10
Clinical Cardiology|October 29, 2015
Effects of Anxiety and Depression on Arterial Elasticity of Subjects With Suboptimal Physical HealthNingling Sun, Yang Xi, Zhiming Zhu, et al.
Pharmacogenomics and Personalized Medicine|December 25, 2024
Associations Between the Polymorphisms in the Coding Sequence of SLCO1B1 and Blood Lipid Levels Before and After Treatment by Atorvastatin in the Chinese Han Adults with DyslipidemiaChao Chen, Yan Tian, Fengshun Jia, et al.
Blood Pressure|June 2, 2025
Impact of amlodipine-based therapy on blood pressure time in target range in Chinese adults with primary hypertension: a retrospective studyHongyi Wang, Yuqing Zhang, Jinxiu Lin, et al.
Advances in Therapy|February 10, 2025
Real-World Multicenter Registry to Determine Management and Quality of Care of Patients with Type 2 Diabetes, Hypertension, Heart Failure and/or Chronic Kidney Diseases in China (iCaReMe China)Xiaoling Cai, Wenjia Yang, Bo Feng, et al.
American Journal of Hypertension|January 25, 2021
A Method for Estimating 24-Hour Urinary Sodium Excretion by Casual Urine Specimen in Chinese Hypertensive PatientsYan Sun, Hongyi Wang, Hao Liang, et al.
International Journal of Cancer|January 23, 2013
Folic acid supplementation and cancer risk: a meta-analysis of randomized controlled trialsXianhui Qin, Yimin Cui, Lin Shen, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|July 16, 2024
The prevalence of monotherapy and combination therapy in hypertension in China from 2019 to 2021: A nationwide population-based cross-sectional studyXiaoyang Luo, Wei Liu, Ningling Sun, et al.
Experimental and Therapeutic Medicine|April 29, 2017
Efficacy and tolerability of once-daily 160 mg valsartan in Chinese patients with mild to moderate hypertensionNingling Sun, Yingqing Feng, Pingjin Gao, et al.
Pharmacogenetics and Genomics|June 7, 2024
Exploring CYP2D6 polymorphisms and angiotensin receptor blocker response in the Bai hypertensive populationCanbiao Yang, Guoqiang Zhang, Chang Shu, et al.
Hypertension (Dallas, Tex. : 1979)|January 22, 2014
Efficacy and safety of LCZ696, a first-in-class angiotensin receptor neprilysin inhibitor, in Asian patients with hypertension: a randomized, double-blind, placebo-controlled studyKazuomi Kario, Ningling Sun, Fu-Tien Chiang, et al.
Pageof 10